VANCOUVER, British Columbia – Rubicon Organics Inc. acquired an operational, purpose-built 47,500-sq.-ft. indoor cultivation facility in Hope, British Columbia, from MediPharm Labs for $4.5 million in cash. The acquisition is a key milestone in Rubicon’s growth strategy to expand premium and certified organic cannabis production.
“This acquisition marks a transformative step in scaling our premium cannabis platform,” said Margaret Brodie, Chief Executive Officer. “With the Hope Facility, we are going beyond just increasing production—we’re building capacity for further innovation, product development, and international expansion, all while reinforcing our existing leadership in the premium segment.”
The Hope Facility is equipped with advanced cultivation technology, supporting Rubicon Organics’ strategy to expand its premium product offerings and increasing supply to meet rising demand. The Company estimates annual production capacity of the Hope Facility to be up to 4,500 kgs, representing more than a 40% increase compared with our current annual production capacity from the Delta Facility, bringing total annual production capacity to 15,500 kg of premium cannabis.
Pending licensing timing expected sometime in the summer, the company expects all cultivation rooms to be planted by the end of 2025 with full production capacity level targets reached by the end of 2026. Executives plan to outlay just over $3 million in operating startup costs during 2025 but do not expect revenue contribution until the first half 2026.
About Rubicon Organics Inc.
Rubicon Organics is a Canadian leader in premium, certified organic and premium cannabis. With a vertically integrated model and strong national distribution, the Company is scaling a house of brands including Simply Bare Organic, 1964 Supply Co., Wildflower, and Homestead Cannabis Supply.
